Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

The Esaote Group presents its latest solutions for cardiac imaging at the EACVI Congress in Barcelona (Spain)

BARCELONA, Spain, May 11, 2023 /PRNewswire/ -- Esaote, one of the world's leading manufacturers of medical diagnostic systems (specifically, ultrasound, dedicated MRI and Medical IT systems) took part in the Congress held by the European Association of Cardiovascular Imaging inBarcelona on May 10...

2023-05-11 21:27 3304

The Esaote Group presents its latest solutions for cardiac imaging at the EACVI Congress in Barcelona (Spain)

CytoMed Therapeutics to Ring Nasdaq Closing Bell

SINGAPORE, May 11, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited ("CytoMed" or the "Company") (Nasdaq: GDTC), a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for the treatment of human cancers, will ...

2023-05-11 21:00 3441

Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology

JINAN, China, May 11, 2023 /PRNewswire/ -- On May 8, 2023, the authoritative oncology journal, Journal of Hematology & Oncology (JHO, 2022 impact factor of 23.168) published the results of the Phase I clinical study of Qilu Pharma's immunotherapy bifunctional antibody, QL1706 (Title: First-in-hum...

2023-05-11 20:55 2240

Health In Tech Partners with ClaimsBridge For Network Management Services

The collaboration will provide self-funded clients with unparalleled access to providers and discounts that are unique in the industry STUART, Fla., May 11, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and reimaginesself-funded he...

2023-05-11 20:30 2212

KT&G reports 2023 Q1 results, on track to become a 'global top-tier' company

* Q1 revenue of KRW 1.396 trillion, operating profit of KRW 316.5 billion * Continued robust growth in combustibles and Heat Not Burn, fundamentals intact * Overseas Heat Not Burn sales volume and operating profit up 64.3%, 127% YoY * Overseas subsidiaries sales volume and revenue up 60%, 4...

2023-05-11 19:45 3471

Invivoscribe Announces IVDR Approval of the LeukoStrat CDx FLT3 Mutation Assay

SAN DIEGO, May 11, 2023 /PRNewswire/ -- "Today we are pleased to announce that Invivoscribe's LeukoStrat® CDx FLT3 Mutation Assay has been approved by BSI ( Netherlands) and the EMA as a Class C CDx assay, meeting the stringent new IVDR (Regulation (EU) 2017/746) requirements. Invivoscribe is one ...

2023-05-11 18:00 2336

PFIZER CALLS FOR MORE AWARENESS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) - A RARE, LIFE-THREATENING DISEASE

KUALA LUMPUR, Malaysia, May 11, 2023 /PRNewswire/ -- In an effort to encourage people to take care of their heart health, Pfizer Malaysia is calling for Malaysians to learn more about transthyretin amyloid cardiomyopathy (ATTR-CM), a rare, life-threatening disease. ATTR-CM is caused by unstable ...

2023-05-11 16:10 2683

PFIZER CALLS FOR MORE AWARENESS OF TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM) - A RARE, LIFE-THREATENING DISEASE

CEAT Ambernath plant receives five-star grading in British Safety Council Audit

CEAT Specialty (division of CEAT Tyres) is proud to announce that it's Ambernath facility has received a Five Star rating in the Occupational Health and Safety Audit conducted by the British Safety Council MUMBAI, India, May 11, 2023 /PRNewswire/ -- The company's Ambernath plant underwent a comp...

2023-05-11 16:05 2585

Nippon Express Italia Obtains IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

TOKYO, May 11, 2023 /PRNewswire/ -- Nippon Express Italia S.p.A. (hereinafter "NX Italia"), a group company of NIPPON EXPRESS HOLDINGS, INC., has acquired IATA CEIV Pharma certification*, a quality certificate for pharmaceutical transport established by the International Air Transport Association...

2023-05-11 14:00 2353

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

ZUG, Switerland, May 11, 2023 /PRNewswire/ -- SHL Medical, a world-leading provider of advanced drug delivery solutions, announced that it has signed a collaboration agreement with MoonLake Immunotherapeutics, a clinical-stage biotechnology company focused on creating next-level therapies for inf...

2023-05-11 09:00 3154

SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector

Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint

ROCKVILLIE, Md. and SUZHOU, China, May 11, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...

2023-05-11 08:45 4387

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements

MACAU, May 10, 2023 /PRNewswire/ -- From May 10 to 12, 2023, the 3rd BEYOND International Technology Innovation Expo — also known as BEYOND Expo 2023is being held at the Venetian Macau Convention and Exhibition Center. This year is the third consecutive year that Fosun Pharma (stock code: 600196....

2023-05-10 22:57 2663

Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements

Late-Breaking Turn Biotechnologies Presentation at ISID to Show Cell Reprogramming with ERA™ Technology Renews Skin

MOUNTAIN VIEW, Calif., May 10, 2023 /PRNewswire/ -- Turn Biotechnologies, a cell reprogramming company developing novel mRNA medicines for untreatable, age-related conditions, has been invited to present data showing that its epigenetic reprogramming technology rejuvenates human skin. Turn Bio's...

2023-05-10 21:00 2331

MomMed Launches "Caring for Mom, Empowering Families" Event with Focus on Giving Back

- Join MomMed in Celebrating Motherhood with Charity Event and Product Promotions NEW YORK, May 10, 2023 /PRNewswire/ -- Leading maternal and baby industry brand, MomMed, has announced its largest event of the first half of the year, themed"Caring for Mom, Empowering Families"

2023-05-10 21:00 1935

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma

* Marketing Authorization granted for Tibsovo® as the first and only approved IDH1 targeted therapyin Europe * IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma, difficult and hard-to-treat cancer PARIS, May 10, 2023 /PRNewswire/ -- Servier, a global pharmaceutical group...

2023-05-10 20:58 1828

Servier receives European Commission approval of Tibsovo® (ivosidenib tablets) in IDH1-mutated Acute Myeloid Leukemia and IDH1-mutated Cholangiocarcinoma

Zepp Health Corporation to Report First Quarter 2023 Financial Results on May 23, 2023

Earnings Call Scheduled for 8:00 a.m. ET on May 23, 2023 BEIJING, May 10, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report its f...

2023-05-10 20:00 2752

Lunit to Present 16 Abstracts at the 2023 ASCO Annual Meeting

- Lunit and collaborators demonstrate the predictive value and analytical prowess of Lunit's AI-biomarker platform in a wide range of cancer types and clinical practices SEOUL, South Korea, May 10, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer di...

2023-05-10 13:44 2216

Lunit to Present 16 Abstracts at the 2023 ASCO Annual Meeting

Doceree forms an exclusive partnership with Hello Health Group to strengthen its global footprint; forays into 8 South East Asian markets

The partnership opens a first-of-its-kind service for Hello Health Group's pharmaceutical clients,enabling them to target HCPs with precision and efficiency NEW DELHI, May 10, 2023 /PRNewswire/ -- Doceree , a leading global platform building unprecedented solutions for h...

2023-05-10 11:00 2845

The China NMPA Approves TYVYT® (sintilimab injection) in Combination with Bevacizumab and Chemotherapy in Patients with EGFR-mutated Non-squamous NSCLC who Progressed after EGFR-TKI Therapy

ROCKVILLIE, Md. and SUZHOU, China, May 10, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ...

2023-05-10 08:00 3367

Gencurix announced Korean and Japanese cancer patients' 15-year follow-up prognostic test clinical results

SEOUL, South Korea, May 9, 2023 /PRNewswire/ -- Gencurix announced clinical results of its prognostic test for breast cancer patients at the Global Breast Cancer Conference 2023. The study, 'Long-term prognostic value of GenesWellBCT score in Asian women ...

2023-05-10 08:00 2329

1 ... 158 159 160161162 163 164 ... 808